Abstract
A new class of oligodeoxyribonucleotides has been designed, referred to here as 'self-stabilized' oligonucleotides. These oligonucleotides have hairpin loop structures at their 3' ends, and show increased resistance to degradation by snake venom phosphodiesterase, DNA polymerase I and fetal bovine serum. The self-stabilized region of the oligonucleotide does not interfere in hybridization with complementary nucleic acids as shown by melting temperature, mobility-shift and RNase H cleavage studies. Various self-stabilized oligonucleotides containing increasingly stable hairpin loop regions were studied for their anti-HIV activity. Pharmacokinetic and stability studies in mice showed increased in vivo persistence of self-stabilized oligonucleotides with respect to their linear counterparts.
MeSH Terms
Animals
Antiviral Agents/chemical synthesis,chemistry,pharmacology
Base Sequence
Blood
Cattle
Cells, Cultured
DNA Polymerase I/metabolism
Drug Stability
Genes, gag
HIV-1/drug effects,physiology
Humans
Lymphocytes
Molecular Sequence Data
Nucleic Acid Conformation
Nucleic Acid Hybridization
Oligonucleotides, Antisense/chemical synthesis,chemistry,pharmacology
Oligoribonucleotides/metabolism
Phosphoric Diester Hydrolases/metabolism
RNA, Viral/metabolism
Ribonuclease H/metabolism
Thionucleotides
Virus Replication/drug effects
Chemicals
Antiviral Agents
Oligonucleotides, Antisense
Oligoribonucleotides
RNA, Viral
Thionucleotides
DNA Polymerase I
Ribonuclease H
Phosphoric Diester Hydrolases
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Tang J Y
Hybridon, Inc., Worcester, MA 01605.
Temsamani J
Agrawal S
References (21)
21 references, click to expand
-
Detection and differentiation by sandwich enzyme-linked immunosorbent assay of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus- and acquired immunodeficiency syndrome-associated retroviruslike clinical isolates.
J Clin Microbiol. 1986 Sep;24(3):424-30
PMID: 2428827
-
Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates.
Proc Natl Acad Sci U S A. 1993 May 1;90(9):3860-4
PMID: 8483903
-
Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus.
Proc Natl Acad Sci U S A. 1988 Oct;85(19):7079-83
PMID: 3174622
-
Synthesis of phosphorothioate analogues of oligodeoxyribonucleotides and their antiviral activity against human immunodeficiency virus (HIV).
Gene. 1988 Dec 10;72(1-2):343-7
PMID: 3243433
-
Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells.
Proc Natl Acad Sci U S A. 1989 Jun;86(11):4244-8
PMID: 2471199
-
Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues.
Proc Natl Acad Sci U S A. 1989 Oct;86(20):7790-4
PMID: 2682627
-
Inhibition of influenza virus replication by phosphorothioate oligodeoxynucleotides.
Proc Natl Acad Sci U S A. 1990 May;87(9):3430-4
PMID: 2333292
-
Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides.
Antimicrob Agents Chemother. 1990 May;34(5):808-12
PMID: 2163243
-
Modified deoxyoligonucleotides stable to exonuclease degradation in serum.
Nucleic Acids Res. 1991 Feb 25;19(4):747-50
PMID: 1850122
-
Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element.
Nucleic Acids Res. 1991 Jun 25;19(12):3359-68
PMID: 2062653
-
Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.
Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7595-9
PMID: 1881900
-
Anti-AIDS agents, 3. Inhibitory effects of colchicine derivatives on HIV replication in H9 lymphocyte cells.
J Nat Prod. 1991 Mar-Apr;54(2):632-7
PMID: 1919593
-
In vivo studies with phosphorothioate oligonucleotides: pharmacokinetics prologue.
Anticancer Drug Des. 1991 Dec;6(6):531-8
PMID: 1772568
-
In vivo stability and kinetics of absorption and disposition of 3' phosphopropyl amine oligonucleotides.
Nucleic Acids Res. 1992 Jan 25;20(2):307-14
PMID: 1741256
-
Antisense oligonucleotides as antiviral agents.
Trends Biotechnol. 1992 May;10(5):152-8
PMID: 1368317
-
Strategies for administering targeted therapeutic oligodeoxynucleotides.
Trends Biotechnol. 1992 Aug;10(8):281-7
PMID: 1368381
-
Antimalarial activities of oligodeoxynucleotide phosphorothioates in chloroquine-resistant Plasmodium falciparum.
Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8577-80
PMID: 1528864
-
Antisense effect of oligodeoxynucleotides with inverted terminal internucleotidic linkages: a minimal modification protecting against nucleolytic degradation.
Antisense Res Dev. 1992 Summer;2(2):129-46
PMID: 1392536
-
Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment.
Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11209-13
PMID: 1454800
-
GEM 91--an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS.
Antisense Res Dev. 1992 Winter;2(4):261-6
PMID: 1363378
-
Oligodeoxynucleotide stability in subcellular extracts and culture media.
J Biochem Biophys Methods. 1986 Sep;13(2):97-102
PMID: 3772027